최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Stem cells international, v.2017, 2017년, pp.3945403 -
Ji, Seung Taek (Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University School of Medicine, Yangsan, Republic of Korea) , Kim, Hyunyun (Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University School of Medicine, Yangsan, Republic of Korea) , Yun, Jisoo (Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University School of Medicine, Yangsan, Republic of Korea) , Chung, Joo Seop (Department of Internal Medicine, Medical Research Institute, Pusan National University School of Medicine, Busan, Republic of Korea) , Kwon, Sang-Mo (Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University School of Medicine, Yangsan, Republic of Korea)
The primary cause of death among chronic diseases worldwide is ischemic cardiovascular diseases, such as stroke and myocardial infarction. Recent evidence indicates that adult stem cell therapies involving cardiovascular regeneration represent promising strategies to treat cardiovascular diseases. O...
1 GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 cause of death, 1990–2013: a systematic analysis for the global burden of disease study 2013 The Lancet 2015 385 9963 117 171
2 Guttmacher A. E. Collins F. S. Nabel E. G. Cardiovascular disease New England Journal of Medicine 2003 349 1 60 72 10.1056/nejmra035098 12840094
3 Meads C. Cummins C. Jolly K. Stevens A. Burls A. Hyde C. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review Health Technology Assessment 2000 4 23 1 153 2-s2.0-0033658103
4 Henry T. D. Annex B. H. McKendall G. R. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis Circulation 2003 107 10 1359 1365 10.1161/01.cir.0000061911.47710.8a 2-s2.0-0037453099 12642354
5 Rozanski A. Blumenthal J. A. Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy Circulation 1999 99 16 2192 2217 10.1161/01.CIR.99.16.2192 2-s2.0-0033608949 10217662
6 Segers V. F. M. Lee R. T. Stem-cell therapy for cardiac disease Nature 2008 451 7181 937 942 10.1038/nature06800 2-s2.0-39749105397 18288183
7 Liechty K. W. MacKenzie T. C. Shaaban A. F. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep Nature Medicine 2000 6 11 1282 1286 10.1038/81395 2-s2.0-0033678140
8 Pittenger M. F. Martin B. J. Mesenchymal stem cells and their potential as cardiac therapeutics Circulation Research 2004 95 1 9 20 10.1161/01.RES.0000135902.99383.6f 2-s2.0-3142663241 15242981
9 Pittenger M. F. Mackay A. M. Beck S. C. Multilineage potential of adult human mesenchymal stem cells Science 1999 284 5411 143 147 10.1126/science.284.5411.143 2-s2.0-0033515827 10102814
10 Ullah I. Subbarao R. B. Rho G. J. Human mesenchymal stem cells—current trends and future prospective Bioscience Reports 2015 35 e00191 10.1042/bsr20150025 2-s2.0-84928991566
11 Nombela-Arrieta C. Ritz J. Silberstein L. E. The elusive nature and function of mesenchymal stem cells Nature Reviews Molecular Cell Biology 2011 12 2 126 131 10.1038/nrm3049 2-s2.0-78951490649 21253000
12 Atoui R. Chiu R. C. J. Mesenchymal stromal cells as universal donor cells Expert Opinion on Biological Therapy 2012 12 10 1293 1297 10.1517/14712598.2012.711307 2-s2.0-84866245913 22827599
13 Faiella W. Atoui R. Therapeutic use of stem cells for cardiovascular disease Clinical and Translational Medicine 2016 5 1, article 34 10.1186/s40169-016-0116-3
14 Le Blanc K. Tammik C. Rosendahl K. Zetterberg E. Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells Experimental Hematology 2003 31 10 890 896 10.1016/S0301-472X(03)00110-3 2-s2.0-0141484485 14550804
15 Stagg J. Pommey S. Eliopoulos N. Galipeau J. Interferon- γ -stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell Blood 2006 107 6 2570 2577 10.1182/blood-2005-07-2793 2-s2.0-33644799418 16293599
16 Patel D. M. Shah J. Srivastava A. S. Therapeutic potential of mesenchymal stem cells in regenerative medicine Stem Cells International 2013 2013 15 496218 10.1155/2013/496218 2-s2.0-84876536833
17 Li L. Chen X. Wang W. E. Zeng C. How to improve the survival of transplanted mesenchymal stem cell in ischemic heart? Stem Cells International 2016 2016 14 9682757 10.1155/2016/9682757 2-s2.0-84949293824
18 Karp J. M. Teo G. S. L. Mesenchymal stem cell homing: the devil is in the details Cell Stem Cell 2009 4 3 206 216 10.1016/j.stem.2009.02.001 2-s2.0-60849136593 19265660
19 Baraniak P. R. McDevitt T. C. Stem cell paracrine actions and tissue regeneration Regenerative Medicine 2010 5 1 121 143 10.2217/rme.09.74 2-s2.0-77649285139 20017699
20 Zippel N. Schulze M. Tobiasch E. Biomaterials and mesenchymal stem cells for regenerative medicine Recent patents on biotechnology 2010 4 1 1 22 10.2174/187220810790069497 2-s2.0-77952485896 20201799
21 Caplan A. I. Mesenchymal stem cells Journal of Orthopaedic Research 1991 9 5 641 650 10.1002/jor.1100090504 2-s2.0-0026228558 1870029
22 Friedenstein A. J. Chailakhjan R. K. Lalykina K. S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells Cell and Tissue Kinetics 1970 3 4 393 403 2-s2.0-0014855869 5523063
23 Friedenstein A. J. Gorskaja U. F. Kulagina N. N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs Experimental Hematology 1976 4 5 267 274 2-s2.0-0017119380 976387
24 Hass R. Kasper C. Böhm S. Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC Cell Communication and Signaling 2011 9, article 12 10.1186/1478-811x-9-12 2-s2.0-79955795428
25 Franco Lambert A. P. Fraga Zandonai A. Bonatto D. Cantarelli Machado D. Pêgas Henriques J. A. Differentiation of human adipose-derived adult stem cells into neuronal tissue: does it work? Differentiation 2009 77 3 221 228 10.1016/j.diff.2008.10.016 2-s2.0-61449114827 19272520
26 Gronthos S. Franklin D. M. Leddy H. A. Robey P. G. Storms R. W. Gimble J. M. Surface protein characterization of human adipose tissue-derived stromal cells Journal of Cellular Physiology 2001 189 1 54 63 10.1002/jcp.1138 2-s2.0-0034829424 11573204
27 Rodriguez A.-M. Elabd C. Amri E.-Z. Ailhaud G. Dani C. The human adipose tissue is a source of multipotent stem cells Biochimie 2005 87 1 125 128 10.1016/j.biochi.2004.11.007 2-s2.0-14544305075 15733747
28 Lindroos B. Boucher S. Chase L. Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro Cytotherapy 2009 11 7 958 972 10.3109/14653240903233081 2-s2.0-70450182933 19903107
29 Schreml S. Babilas P. Fruth S. Harvesting human adipose tissue-derived adult stem cells: resection versus liposuction Cytotherapy 2009 11 7 947 957 10.3109/14653240903204322 2-s2.0-70450180838 19903106
30 Sensebé L. Bourin P. Mesenchymal stem cells for therapeutic purposes Transplantation 2009 87 9S S49 53 10.1097/tp.0b013e3181a28635 2-s2.0-67649871059 19424006
31 Alsalameh S. Amin R. Gemba T. Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage Arthritis and Rheumatism 2004 50 5 1522 1532 10.1002/art.20269 2-s2.0-2342547689 15146422
32 Hiraoka K. Grogan S. Olee T. Lotz M. Mesenchymal progenitor cells in adult human articular cartilage Biorheology 2006 43 3-4 447 454 2-s2.0-33747097813 16912416
33 Secco M. Moreira Y. B. Zucconi E. Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood Stem Cell Reviews and Reports 2009 5 4 387 401 10.1007/s12015-009-9098-5 2-s2.0-74649084974 20058202
34 Jäger M. Zilkens C. Bittersohl B. Krauspe R. Cord blood—an alternative source for bone regeneration Stem Cell Reviews and Reports 2009 5 3 266 277 10.1007/s12015-009-9083-z 2-s2.0-70349615818 19652969
35 Bieback K. Klüter H. Mesenchymal stromal cells from umbilical cord blood Current Stem Cell Research and Therapy 2007 2 4 310 323 10.2174/157488807782793763 2-s2.0-38349090170 18220915
36 Campagnoli C. Roberts I. A. G. Kumar S. Bennett P. R. Bellantuono I. Fisk N. M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow Blood 2001 98 8 2396 2402 10.1182/blood.V98.8.2396 2-s2.0-0035889146 11588036
37 Zvaifler N. J. Marinova-Mutafchieva L. Adams G. Mesenchymal precursor cells in the blood of normal individuals Arthritis Research 2000 2 6 477 488 10.1186/ar130 2-s2.0-0034468279 11056678
38 da Silva Meirelles L. Chagastelles P. C. Nardi N. B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues Journal of Cell Science 2006 119 11 2204 2213 10.1242/jcs.02932 2-s2.0-33745503987 16684817
39 Dominici M. Le Blanc K. Mueller I. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 2006 8 4 315 317 10.1080/14653240600855905 2-s2.0-33747713246 16923606
40 Horwitz E. M. Le Blanc K. Dominici M. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement Cytotherapy 2005 7 5 393 395 10.1080/14653240500319234 2-s2.0-27944435821 16236628
41 Haynesworth S. E. Barer M. A. Caplan A. I. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies Bone 1992 13 1 69 80 10.1016/8756-3282(92)90363-2 2-s2.0-0026525255 1316137
42 Conget P. A. Minguell J. J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells Journal of Cellular Physiology 1999 181 1 67 73 10.1002/(sici)1097-4652(199910)181:1 3.0.co;2-c 2-s2.0-0032768790 10457354
43 Hong J.-H. Hwang E. S. McManus M. T. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation Science 2005 309 5737 1074 1078 10.1126/science.1110955 2-s2.0-23644431709 16099986
44 Caplan A. I. Bruder S. P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century Trends in Molecular Medicine 2001 7 6 259 264 10.1016/s1471-4914(01)02016-0 2-s2.0-0034975453 11378515
45 Short B. Brouard N. Occhiodoro-Scott T. Ramakrishnan A. Simmons P. J. Mesenchymal stem cells Archives of Medical Research 2003 34 6 565 571 10.1016/j.arcmed.2003.09.007 14734097
46 Augello A. De Bari C. The regulation of differentiation in mesenchymal stem cells Human Gene Therapy 2010 21 10 1226 1238 10.1089/hum.2010.173 2-s2.0-77958096064 20804388
47 Song H. Chang W. Song B. W. Hwang K. C. Specific differentiation of mesenchymal stem cells by small molecules American Journal of Stem Cells 2012 1 1 22 30 23671794
48 Mahjneh I. Passos-Bueno M.-R. Zatz M. The phenotype of chromosome 2p-linked limb-girdle muscular dystrophy Neuromuscular Disorders 1996 6 6 483 490 10.1016/S0960-8966(96)00390-2 2-s2.0-0030477874 9027859
49 Mackay A. M. Beck S. C. Murphy J. M. Barry F. P. Chichester C. O. Pittenger M. F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow Tissue Engineering 1998 4 4 415 428 10.1089/ten.1998.4.415 2-s2.0-0031728565 9916173
50 Sato Y. Araki H. Kato J. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion Blood 2005 106 2 756 763 10.1182/blood-2005-02-0572 2-s2.0-22144460191 15817682
51 Toma C. Pittenger M. F. Cahill K. S. Byrne B. J. Kessler P. D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 2002 105 1 93 98 10.1161/hc0102.101442 2-s2.0-0036142213 11772882
52 Williams A. R. Hare J. M. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease Circulation Research 2011 109 8 923 940 10.1161/circresaha.111.243147 2-s2.0-80053552289 21960725
53 Xu W. Zhang X. Qian H. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro Experimental Biology and Medicine 2004 229 7 623 631 2-s2.0-3042856796 15229356
54 Kim Y. S. Kwon J. S. Hong M. H. Promigratory activity of oxytocin on umbilical cord blood-derived mesenchymal stem cells Artificial Organs 2010 34 6 453 461 10.1111/j.1525-1594.2009.00894.x 2-s2.0-77953180688 20624160
55 Lim S. Y. Kim Y. S. Ahn Y. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model Cardiovascular Research 2006 70 3 530 542 10.1016/j.cardiores.2006.02.016 2-s2.0-33646676295 16563361
56 Quevedo H. C. Hatzistergos K. E. Oskouei B. N. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity Proceedings of the National Academy of Sciences of the United States of America 2009 106 33 14022 14027 10.1073/pnas.0903201106 2-s2.0-69549138471 19666564
57 Wang D. Zhang F. Shen W. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats International Journal of Cardiology 2011 152 3 314 320 10.1016/j.ijcard.2010.07.025 2-s2.0-80055045664 20674997
58 Hare J. M. Traverse J. H. Henry T. D. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction Journal of the American College of Cardiology 2009 54 24 2277 2286 10.1016/j.jacc.2009.06.055 2-s2.0-70549103270 19958962
59 Trachtenberg B. Velazquez D. L. Williams A. R. Rationale and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: a randomized, double-blind, placebo-controlled study of safety and efficacy American Heart Journal 2011 161 3 487 493 10.1016/j.ahj.2010.11.024 2-s2.0-79952405279 21392602
60 Hare J. M. Translational development of mesenchymal stem cell therapy for cardiovascular diseases Texas Heart Institute Journal 2009 36 2 145 147 2-s2.0-65949099706 19436809
61 Sanina C. Hare J. M. Mesenchymal stem cells as a biological drug for heart disease: where are we with cardiac cell-based therapy? Circulation Research 2015 117 3 229 233 10.1161/circresaha.117.306306 2-s2.0-84937554663 26185208
62 Squillaro T. Peluso G. Galderisi U. Clinical trials with mesenchymal stem cells: an update Cell Transplantation 2016 25 5 829 848 10.3727/096368915x689622 2-s2.0-84964273471 26423725
63 Mathiasen A. B. Haack-Sørensen M. Jørgensen E. Kastrup J. Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina—final 3-year follow-up International Journal of Cardiology 2013 170 2 246 251 10.1016/j.ijcard.2013.10.079 2-s2.0-84889088207 24211066
64 Williams A. R. Trachtenberg B. Velazquez D. L. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling Circulation Research 2011 108 7 792 796 10.1161/circresaha.111.242610 2-s2.0-79954928346 21415390
65 Lee J.-W. Lee S.-H. Youn Y.-J. A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction Journal of Korean Medical Science 2014 29 1 23 31 10.3346/jkms.2014.29.1.23 2-s2.0-84907424372 24431901
66 Gyöngyösi M. Wojakowski W. Lemarchand P. Meta-analysis of cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data Circulation Research 2015 116 8 1346 1360 10.1161/CIRCRESAHA.116.304346 2-s2.0-84929003354 25700037
67 Kharlamov A. N. Tyurnina A. E. Veselova V. S. Kovtun O. P. Shur V. Y. Gabinsky J. L. Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial Nanoscale 2015 7 17 8003 8015 10.1039/c5nr01050k 2-s2.0-84929494405 25864858
68 Hare J. M. Fishman J. E. Gerstenblith G. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial The Journal of the American Medical Association 2012 308 22 2369 2379 23117550
69 Heldman A. W. DiFede D. L. Fishman J. E. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial JAMA 2014 311 1 62 73 10.1001/jama.2013.282909 2-s2.0-84891941987 24247587
70 Karantalis V. Difede D. L. Gerstenblith G. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial Circulation Research 2014 114 8 1302 1310 10.1161/circresaha.114.303180 2-s2.0-84898841773 24565698
71 Matsui T. Tao J. Del Monte F. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo Circulation 2001 104 3 330 335 10.1161/01.CIR.104.3.330 2-s2.0-0035902451 11457753
72 Mangi A. A. Noiseux N. Kong D. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts Nature Medicine 2003 9 9 1195 1201 10.1038/nm912 2-s2.0-0141796313
73 Tamama K. Fan V. H. Griffith L. G. Blair H. C. Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells Stem Cells 2006 24 3 686 695 10.1634/stemcells.2005-0176 2-s2.0-33744979059 16150920
74 Fan V. H. Au A. Tamama K. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells Stem Cells 2007 25 5 1241 1251 10.1634/stemcells.2006-0320 2-s2.0-34247638937 17234993
75 Michalis Mastri H. L. Lee T. Enhancing the efficacy of mesenchymal stem cell therapy World Journal of Stem Cells 2014 6 2 82 93 24772236
76 Yoon D. S. Kim Y. H. Jung H. S. Paik S. Lee J. W. Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture Cell Proliferation 2011 44 5 428 440 10.1111/j.1365-2184.2011.00770.x 2-s2.0-80053168047 21951286
77 Liu T. M. Wu Y. N. Guo X. M. Hui J. H. P. Lee E. H. Lim B. Effects of ectopic nanog and Oct4 overexpression on mesenchymal stem cells Stem Cells and Development 2009 18 7 1013 1022 10.1089/scd.2008.0335 2-s2.0-66149126375 19102659
78 Han S.-M. Han S.-H. Coh Y.-R. Enhanced proliferation and differentiation of Oct4- And Sox2-overexpressing human adipose tissue mesenchymal stem cells Experimental and Molecular Medicine 2014 46 6, article no. e101 10.1038/emm.2014.28 2-s2.0-84902126864
79 Komiya Y. Habas R. Wnt signal transduction pathways Organogenesis 2008 4 2 68 75 10.4161/org.4.2.5851 2-s2.0-45849117967 19279717
80 Nusse R. Wnt signaling and stem cell control Cell Research 2008 18 5 523 527 10.1038/cr.2008.47 2-s2.0-43049144313 18392048
81 Staal F. J. T. Luis T. C. Wnt signaling in hematopoiesis: crucial factors for self-renewal, proliferation, and cell fate decisions Journal of Cellular Biochemistry 2010 109 5 844 849 10.1002/jcb.22467 2-s2.0-77950413430 20069555
82 Boland G. M. Perkins G. Hall D. J. Tuan R. S. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells Journal of Cellular Biochemistry 2004 93 6 1210 1230 10.1002/jcb.20284 2-s2.0-11144296595 15486964
83 Zhu Z. Yin J. Guan J. Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3 β -dependent β -catenin/Wnt pathway activation FEBS Journal 2014 281 23 5371 5389 10.1111/febs.13081 2-s2.0-84922481157 25265417
84 Guan S. Wang Z. Xin F. Xin H. Wnt5a is associated with the differentiation of bone marrow mesenchymal stem cells in vascular calcification by connecting with different receptors Molecular Medicine Reports 2014 10 4 1985 1991 10.3892/mmr.2014.2449 2-s2.0-84924219800 25109262
85 Bilkovski R. Schulte D. M. Oberhauser F. Role of Wnt-5a in the determination of human mesenchymal stem cells into preadipocytes The Journal of Biological Chemistry 2010 285 9 6170 6178 10.1074/jbc.m109.054338 2-s2.0-77949909802 20032469
86 Hong L. Zhang G. Sultana H. Yu Y. Wei Z. The effects of 17- β estradiol on enhancing proliferation of human bone marrow mesenchymal stromal cells in vitro Stem Cells and Development 2011 20 5 925 931 10.1089/scd.2010.0125 2-s2.0-79955759383 20735179
87 Cheng Z. Ou L. Zhou X. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance Molecular Therapy 2008 16 3 571 579 10.1038/sj.mt.6300374 2-s2.0-39849097361 18253156
88 Oh S. Y. Lee S.-J. Jung Y. H. Lee H. J. Han H. J. Arachidonic acid promotes skin wound healing through induction of human MSC migration by MT3-MMP-mediated fibronectin degradation Cell Death and Disease 2015 6 5 10.1038/cddis.2015.114 2-s2.0-84953371939
89 Kean T. J. Duesler L. Young R. G. Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell Journal of Drug Targeting 2012 20 1 23 32 10.3109/1061186X.2011.622398 2-s2.0-83155191797 22047107
90 Liu J. Zhu P. Song P. Pretreatment of adipose derived stem cells with curcumin facilitates myocardial recovery via antiapoptosis and angiogenesis Stem Cells International 2015 2015 12 638153 10.1155/2015/638153 2-s2.0-84930011780
91 Liu X.-B. Chen H. Chen H.-Q. Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation Journal of Zhejiang University: Science B 2012 13 8 616 623 10.1631/jzus.b1201004 2-s2.0-84866059036 22843181
92 Haider H. K. Ashraf M. Preconditioning and stem cell survival Journal of Cardiovascular Translational Research 2010 3 2 89 102 10.1007/s12265-009-9161-2 2-s2.0-77953617367 20560023
93 Balana B. Nicoletti C. Zahanich I. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells Cell Research 2006 16 12 949 960 10.1038/sj.cr.7310116 2-s2.0-33845748551 17160070
94 Liu Y. Song J. Liu W. Wan Y. Chen X. Hu C. Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovascular Research 2003 58 2 460 468 10.1016/s0008-6363(03)00265-7 2-s2.0-0038030816 12757880
95 Gai H. Leung E. L.-H. Costantino P. D. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts Cell Biology International 2009 33 11 1184 1193 10.1016/j.cellbi.2009.08.008 2-s2.0-70350605496 19729070
96 Bin Z. Sheng L.-G. Gang Z.-C. Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells Cell Biology International 2006 30 10 769 776 10.1016/j.cellbi.2006.05.011 2-s2.0-33750013930 16831561
97 Hou J. Lü A.-L. Liu B.-W. Combination of BMP-2 and 5-AZA is advantageous in rat bone marrow-derived mesenchymal stem cells differentiation into cardiomyocytes Cell Biology International 2013 37 12 1291 1299 10.1002/cbin.10161 2-s2.0-84888432096 23881855
98 Liu C. Fan Y. Zhou L. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction International Journal of Cardiology 2015 188 1 22 32 10.1016/j.ijcard.2015.03.425 2-s2.0-84929302745 25880576
99 Lee J. H. Ryu J. M. Han Y.-S. Fucoidan improves bioactivity and vasculogenic potential of mesenchymal stem cells in murine hind limb ischemia associated with chronic kidney disease Journal of Molecular and Cellular Cardiology 2016 97 169 179 10.1016/j.yjmcc.2016.05.011 2-s2.0-84971477064 27216370
100 Elnakish M. T. Hassan F. Dakhlallah D. Marsh C. B. Alhaider I. A. Khan M. Mesenchymal stem cells for cardiac regeneration: translation to bedside reality Stem Cells International 2012 2012 14 646038 10.1155/2012/646038 2-s2.0-84863646553
101 Breitbach M. Bostani T. Roell W. Potential risks of bone marrow cell transplantation into infarcted hearts Blood 2007 110 4 1362 1369 10.1182/blood-2006-12-063412 2-s2.0-34548044258 17483296
102 Bernhard J. C. Vunjak-Novakovic G. Should we use cells, biomaterials, or tissue engineering for cartilage regeneration? Stem Cell Research and Therapy 2016 7 1, article 56 10.1186/s13287-016-0314-3 2-s2.0-84966267480
103 Kim K. J. Joe Y. A. Kim M. K. Silica nanoparticles increase human adipose tissue-derived stem cell proliferation through ERK1/2 activation International Journal of Nanomedicine 2015 10 2261 2272 10.2147/ijn.s71925 2-s2.0-84928139636 25848249
104 Kim K. J. Jeon Y.-J. Lee J. H. Rhie J.-W. The effect of silicon ion on proliferation and osteogenic differentiation of human ADSCs Korean Tissue Engineering and Regenerative Medicine Society 2010 7 2 171 177
105 Ning L. Malmström H. Ren Y.-F. Porous collagen-Hydroxyapatite scaffolds with mesenchymal stem cells for bone regeneration Journal of Oral Implantology 2015 41 1 45 49 10.1563/AAID-JOI-D-12-00298 2-s2.0-84923830264 23574526
106 Zhang Y.-S. Gao J.-H. Lu F. Zhu M. Liao Y.-J. Cellular compatibility of type collagen I scaffold and human adipose-derived stem cells Nan Fang Yi Ke Da Xue Xue Bao 2007 27 2 223 225 2-s2.0-43549087925 17355943
107 Ishii M. Shibata R. Numaguchi Y. Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 10 2210 2215 10.1161/ATVBAHA.111.231100 2-s2.0-80052968134
108 Yoon I.-S. Chung C. W. Sung J.-H. Proliferation and chondrogenic differentiation of human adipose-derived mesenchymal stem cells in porous hyaluronic acid scaffold Journal of Bioscience and Bioengineering 2011 112 4 402 408 10.1016/j.jbiosc.2011.06.018 2-s2.0-80054017649 21802988
109 Yao R. Zhang R. Luan J. Lin F. Alginate and alginate/gelatin microspheres for human adipose-derived stem cell encapsulation and differentiation Biofabrication 2012 4 2 025007 10.1088/1758-5082/4/2/025007 2-s2.0-84861536459
110 Cheng N.-C. Wang S. Young T.-H. The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities Biomaterials 2012 33 6 1748 1758 10.1016/j.biomaterials.2011.11.049 2-s2.0-83555179053 22153870
111 Mauney J. R. Nguyen T. Gillen K. Kirker-Head C. Gimble J. M. Kaplan D. L. Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds Biomaterials 2007 28 35 5280 5290 10.1016/j.biomaterials.2007.08.017 2-s2.0-34948823819 17765303
112 Zhang H. Zhu S.-J. Wang W. Wei Y.-J. Hu S.-S. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function Gene Therapy 2008 15 1 40 48 10.1038/sj.gt.3303049 2-s2.0-37249094049 17943144
113 Wang Y. Zhang G. Hou Y. Transplantation of microencapsulated Schwann cells and mesenchymal stem cells augment angiogenesis and improve heart function Molecular and Cellular Biochemistry 2012 366 1-2 139 147 10.1007/s11010-012-1291-1 2-s2.0-84862009337 22488214
114 Rosenstein J. M. Krum J. M. Ruhrberg C. VEGF in the nervous system Organogenesis 2010 6 2 107 114 10.4161/org.6.2.11687 2-s2.0-77953494291 20885857
115 Houtgraaf J. H. de Jong R. Monkhorst K. Feasibility of intracoronary GLP-1 eluting cellbead™ infusion in acute myocardial infarction Cell Transplantation 2013 22 3 535 543 22507673
116 Berry M. F. Friedberg J. Chest wall/diaphragmatic complications Thoracic Surgery Clinics 2006 16 3 277 285 10.1016/j.thorsurg.2006.05.007 2-s2.0-33747661007 17004556
117 Wei H.-J. Chen C.-H. Lee W.-Y. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair Biomaterials 2008 29 26 3547 3556 10.1016/j.biomaterials.2008.05.009 2-s2.0-46149099328 18538386
118 Kang H.-W. Lee S. J. Ko I. K. Kengla C. Yoo J. J. Atala A. A 3D bioprinting system to produce human-scale tissue constructs with structural integrity Nature Biotechnology 2016 34 3 312 319 10.1038/nbt.3413 2-s2.0-84960905071
119 Kolesky D. B. Homan K. A. Skylar-Scott M. A. Lewis J. A. Three-dimensional bioprinting of thick vascularized tissues Proceedings of the National Academy of Sciences of the United States of America 2016 113 12 3179 3184 10.1073/pnas.1521342113 2-s2.0-84962238220 26951646
※ AI-Helper는 부적절한 답변을 할 수 있습니다.